In this single-center retrospective study, 155 consecutive patients with leptomeningeal
metastasis (LM) were analyzed for the prognostic role of patient-and therapy-related …

Purpose Leptomeningeal metastases (LM) are associated with very poor prognosis and
data on outcome are limited. We evaluated prognostic factors and treatment options in …

Leptomeningeal metastases (LM) is a common problem in neuro-oncology occurring in
approximately 5% of all patients with cancer. Notwithstanding frequent focal signs and …

BACKGROUND It has been suggested that an aggressive treatment of patients with
leptomeningeal metastases (LM) that groups radiotherapy and intra‐cerebrospinal fluid …

Background Leptomeningeal metastasis (LM) occurs in 4–15% of patients with solid tumors.
Although the clinical outcomes in cancer patients have been improving recently, no standard …

Abstract Meningeal metastasis occurs in 3–8% of all cancer patients, producing neurologic
morbidity and a high mortality. Diagnosis is best established by the demonstration of …

Leptomeningeal metastases (LMM) consist of diffuse involvement of the leptomeninges by
infiltrating cancer cells. In solid tumors, the most frequent primary sites are lung and breast …

Objective: To assess the clinical significance of bulky metastatic central nervous system
disease in patients with leptomeningeal metastases. Patients and Methods: Forty patients …

Metastases to the nervous system are an increasingly common complication of cancer, and
can involve the brain parenchyma, dura, skull, epidural space, peripheral nerves, and …

Leptomeningeal metastasis : Current Opinion in Neurology Leptomeningeal metastasis :
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new issue …